Similar articles

• [Case of Seip-Lawrence syndrome associated with acanthosis nigricans].

  Asano S, Matsuki S, Ozawa Y, Ito K, Saruta T, Sakai H. Asano S, et al. Saishin Igaku. 1966 Apr;21(4):865-70. Saishin Igaku. 1966. PMID: 5973950 Japanese. No abstract available.
• Congenital lipodystrophic diabetes with acanthosis nigricans. The Seip-Lawrence syndrome.

  Reed WB, Dexter R, Corley C, Fish C. Reed WB, et al. Arch Dermatol. 1965 Apr;91(4):326-34. doi: 10.1001/archderm.91.4.326. Arch Dermatol. 1965. PMID: 9626079 No abstract available.
• Treatment of acanthosis nigricans with etretinate (Tigason) in a patient with Lawrence-Seip syndrome (generalized lipodystrophy).

  Mørk NJ, Rajka G, Halse J. Mørk NJ, et al. Acta Derm Venereol. 1986;66(2):173-4. Acta Derm Venereol. 1986. PMID: 2424246
• Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin.

  Rendon MI, Cruz PD Jr, Sontheimer RD, Bergstresser PR. Rendon MI, et al. J Am Acad Dermatol. 1989 Sep;21(3 Pt 1):461-9. doi: 10.1016/s0190-9622(89)70208-5. J Am Acad Dermatol. 1989. PMID: 2674210 Review.
• [Acanthosis nigricans and cancer of the stomach].

  Sarmento JA, Rosário C, Santos C, Allegro S, Massa A, Roquete P. Sarmento JA, et al. Acta Med Port. 1989 Jan-Feb;2(1):31-4. Acta Med Port. 1989. PMID: 2672700 Review. Portuguese.